東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The era of artificial intelligence, ...

Ashenden, Stephanie Kay.

FindBook

Google Book

Amazon

博客來

The era of artificial intelligence, machine learning, and data science in the pharmaceutical industry /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	The era of artificial intelligence, machine learning, and data science in the pharmaceutical industry // edited by Stephanie Kay Ashenden.
其他作者:	Ashenden, Stephanie Kay.
出版者:	London :Academic Press, : c2021.,
面頁冊數:	xvii, 245 p. :ill. (some col.), charts (some col.) ;24 cm.
標題:	Drug development - Data processing. -
ISBN:	9780128200452

The era of artificial intelligence, machine learning, and data science in the pharmaceutical industry /
The era of artificial intelligence, machine learning, and data science in the pharmaceutical industry /edited by Stephanie Kay Ashenden. - London :Academic Press,c2021. - xvii, 245 p. :ill. (some col.), charts (some col.) ;24 cm.

Includes bibliographical references and index.

The Era of Artificial Intelligence, Machine Learning and Data Science in the Pharmaceutical Industry examines the drug discovery process, assessing how new technologies have improved effectiveness. Artificial intelligence and machine learning are considered the future for a wide range of disciplines and industries, including the pharmaceutical industry. In an environment where producing a single approved drug costs millions and takes many years of rigorous testing prior to its approval, reducing costs and time is of high interest. This book follows the journey that a drug company takes when producing a therapeutic, from the very beginning to ultimately benefitting a patient's life. This comprehensive resource will be useful to those working in the pharmaceutical industry, but will also be of interest to anyone doing research in chemical biology, computational chemistry, medicinal chemistry and bioinformatics.

ISBN: 9780128200452US125.00Subjects--Topical Terms:

1965635
Drug development
--Data processing.

LC Class. No.: RS122.2 / E73 2021

Dewey Class. No.: 615.190028563

The era of artificial intelligence, machine learning, and data science in the pharmaceutical industry /
LDR:01644cam a2200181 a 4500 001 2232699
008 210922s2021 enkad f b 001 0 eng
020 $a 9780128200452 $q (pbk.) : $c US125.00
020 $a 0128200456 $q (pbk.)
020 $z 9780128204498 $q (ebk.)
035 $a (OCoLC)1247670455
040 $a YDX $b eng $e aacr2 $c YDX $d OPELS $d OCLCO $d GZM $d N $d OCLCF $d SNM
050 # 4 $a RS122.2 $b E73 2021
082 0 4 $a 615.190028563 $2 23
245 0 4 $a The era of artificial intelligence, machine learning, and data science in the pharmaceutical industry / $c edited by Stephanie Kay Ashenden.
260 # $a London : $b Academic Press, $c c2021.
300 $a xvii, 245 p. : $b ill. (some col.), charts (some col.) ; $c 24 cm.
504 $a Includes bibliographical references and index.
520 # $a The Era of Artificial Intelligence, Machine Learning and Data Science in the Pharmaceutical Industry examines the drug discovery process, assessing how new technologies have improved effectiveness. Artificial intelligence and machine learning are considered the future for a wide range of disciplines and industries, including the pharmaceutical industry. In an environment where producing a single approved drug costs millions and takes many years of rigorous testing prior to its approval, reducing costs and time is of high interest. This book follows the journey that a drug company takes when producing a therapeutic, from the very beginning to ultimately benefitting a patient's life. This comprehensive resource will be useful to those working in the pharmaceutical industry, but will also be of interest to anyone doing research in chemical biology, computational chemistry, medicinal chemistry and bioinformatics.
650 # 0 $a Drug development $x Data processing. $3 1965635
650 # 0 $a Artificial intelligence. $3 516317
650 # 0 $a Pharmaceutical industry $x Data processing. $3 812162
700 1 # $a Ashenden, Stephanie Kay. $3 3500125